Clinical trial

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

NCT05852990

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-03-01

PhasePHASE3

Study timeline

Study start (actual)2022-03-01Date precision: day

Registry last updated2026-04-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancer With EGFR Mutationunresolved

Interventions

Glutamine plus L. reuteriCOMBINATION_PRODUCT

Sponsors & collaborators

Instituto Nacional de Cancerologia de Mexicolead sponsor

Mapped research locations

Mexico CityMexico City, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05852990 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.